CN Patent

CN103052385A — 治疗肝细胞癌的方法

Assigned to Abraxis Bioscience LLC · Expires 2013-04-17 · 13y expired

What this patent protects

本发明提供通过给予包括含有紫杉烷和白蛋白的纳米颗粒的组合物治疗肝细胞癌(HCC)的方法和组合物。本发明还提供治疗HCC的联合治疗方法，包括给予个体有效量的包括含有紫杉烷和白蛋白的纳米颗粒的组合物和另一药剂，如抑制微管拆散的药剂。

USPTO Abstract

本发明提供通过给予包括含有紫杉烷和白蛋白的纳米颗粒的组合物治疗肝细胞癌(HCC)的方法和组合物。本发明还提供治疗HCC的联合治疗方法，包括给予个体有效量的包括含有紫杉烷和白蛋白的纳米颗粒的组合物和另一药剂，如抑制微管拆散的药剂。

Drugs covered by this patent

Taxotere (Docetaxel) · Sanofi

Patent Metadata

Patent number: CN103052385A
Jurisdiction: CN
Classification: —
Expires: 2013-04-17
Drug substance claim: No
Drug product claim: No
Assignee: Abraxis Bioscience LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.